<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.bmj.com">
<title>BMJ Recent Articles</title>
<link>http://www.bmj.com</link>
<description>BMJ RSS feed -- articles published in the last few days</description>
<prism:eIssn>1468-5833</prism:eIssn>
<prism:publicationName>BMJ</prism:publicationName>
<prism:issn>0959-8138</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e1023.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e1031.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e1034.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e821.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e940.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e1020.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e1025.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e346.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e420.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e568.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e667.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e902.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e904.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e907.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e909.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e911.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e912.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e996.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e1000.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e1009.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e536.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e595.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e697.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e844.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e922.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e923.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e971.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e987.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e994.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e1005.short?rss=1" />
  <rdf:li rdf:resource="http://www.bmj.com/content/344/bmj.e630.short?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.bmj.com/icons/site/logo.bmj.gif" />
</channel>
<image rdf:about="http://www.bmj.com/icons/site/logo.bmj.gif">
<title>BMJ</title>
<url>http://www.bmj.com/icons/site/logo.bmj.gif</url>
<link>http://www.bmj.com</link>
</image>
<item rdf:about="http://www.bmj.com/content/344/bmj.e1023.short?rss=1">
<title><![CDATA[Evidence is still not informing policy on obesity, conference hears]]></title>
<link>http://www.bmj.com/content/344/bmj.e1023.short?rss=1</link>
<description><![CDATA[The government is still not making the best use of evidence in efforts to tackle the UK’s grave obesity problem, a conference of experts heard.Julia Neuberger, who chairs the House of Lords Science and Technology sub-committee, said attempts to change people’s behaviour were not being properly evaluated.She said there was insufficient commitment to implement research and called for more to be done to address environmental impacts on obesity.Baroness Neuberger, a cross-bench peer and former chief executive of the King’s Fund, spoke at the Obesity 2012 seminar, held in London on 7 February by Westminster Food and Nutrition Forum.Last year her committee’s inquiry into behaviour change reported that “nudges” used in isolation would not be effective and called for the gathering of more evidence about what measures work.Baroness Neuberger told the seminar the government’s obesity strategy (Healthy Lives. Healthy People: A Call to Action, published in October 2011) showed the need...]]></description>
<dc:creator><![CDATA[Limb, M.]]></dc:creator>
<dc:date>2012-02-10T07:41:33-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e1023</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e1023</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Health policy, Childhood nutrition, Obesity (nutrition), Childhood nutrition (paediatrics), Child health, Health service research, Health education, Obesity (public health), Health promotion]]></dc:subject>
<dc:title><![CDATA[Evidence is still not informing policy on obesity, conference hears]]></dc:title>
<prism:publicationDate>2012-02-10</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb10_2</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e1031.short?rss=1">
<title><![CDATA[Seize the chance to agree a lasting settlement on how to fund social care, says Dilnot]]></title>
<link>http://www.bmj.com/content/344/bmj.e1031.short?rss=1</link>
<description><![CDATA[Politicians will be “cowardly” if they fail to seize the chance to transform the system of funding social care in England, according to the economist leading the case for change.Andrew Dilnot, who chaired the Commission on Funding of Care and Support which reported to ministers last year (BMJ 2011;343:d4261, doi:10.1136/bmj.d4261), said the current system was “completely broken” and reform was long overdue.Now is the time to install a lasting settlement where individuals and the state pool risks in a way that is fairer for most people, especially those with high social care needs, he said. “It would be a cowardly country that failed to take that chance,” he added.Mr Dilnot was speaking at a seminar on social care reform, organised by the Westminster Health Forum on 9 February, the day after the health select committee reported on its inquiry into social care (BMJ 2012;344:e932, 8 Feb, doi:10.1136/bmj.e932).The committee found there...]]></description>
<dc:creator><![CDATA[Limb, M.]]></dc:creator>
<dc:date>2012-02-10T07:41:33-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e1031</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e1031</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Health policy, Sociology]]></dc:subject>
<dc:title><![CDATA[Seize the chance to agree a lasting settlement on how to fund social care, says Dilnot]]></dc:title>
<prism:publicationDate>2012-02-10</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb10_2</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e1034.short?rss=1">
<title><![CDATA[Legal action by patient forces trust to make u turn over non-NHS community health services]]></title>
<link>http://www.bmj.com/content/344/bmj.e1034.short?rss=1</link>
<description><![CDATA[A retired railwayman living in a care home has forced Gloucestershire Primary Care Trust (PCT) to reconsider its plans to hand over community health services to a social enterprise organisation it created for the purpose, which would operate outside the NHS.Michael Lloyd, 76, launched a legal challenge at the High Court in London, arguing that the trust would be acting unlawfully in giving an £80m (€95m; $126m) a year contract to Gloucestershire Care Services (GCS) community interest company without giving NHS organisations a chance to bid.His barrister, David Lock QC, told the court that the move would be unlawful without a fair and transparent procurement exercise. On the second day of a planned two day hearing at the High Court in London, when the trust was due to outline its arguments, it agreed instead to settle the case and abandon its plans to grant the contract to GCS “at this...]]></description>
<dc:creator><![CDATA[Dyer, C.]]></dc:creator>
<dc:date>2012-02-10T07:41:33-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e1034</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e1034</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[General practice / family medicine]]></dc:subject>
<dc:title><![CDATA[Legal action by patient forces trust to make u turn over non-NHS community health services]]></dc:title>
<prism:publicationDate>2012-02-10</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb10_2</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e821.short?rss=1">
<title><![CDATA[The role of regulation in healthcare]]></title>
<link>http://www.bmj.com/content/344/bmj.e821.short?rss=1</link>
<description><![CDATA[In November 2011, the healthcare think tank, the King’s Fund, published an assessment of the responsibilities and prospects for the newly redesigned Monitor, the independent regulator of NHS foundation trusts.1 The report explores several sensitive problems that inevitably face a newly beefed up health sector regulator.Regulation has become an increasingly important part of the political toolbox in European healthcare systems that are funded by taxation. When healthcare providers were directly ruled by a central or regional government office, their decision making discretion was typically limited to informal strategies to create small degrees of autonomy within government directives.2 3 Regulation was rule based, serving mostly to convey higher level political decisions to lower operating levels of the delivery system.With the onset of planned markets in the early 1990s, the role of regulation changed. In a provider market where institutions had some degree of competitive freedom, regulation shifted from conveying a fixed...]]></description>
<dc:creator><![CDATA[Saltman, R. B.]]></dc:creator>
<dc:date>2012-02-10T03:42:34-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e821</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e821</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[The role of regulation in healthcare]]></dc:title>
<prism:publicationDate>2012-02-10</prism:publicationDate>
<prism:section>Editorials</prism:section>
<prism:subsection1>Editorial</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb10_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e940.short?rss=1">
<title><![CDATA[Scaling up oral rehydration salts and zinc for the treatment of diarrhoea]]></title>
<link>http://www.bmj.com/content/344/bmj.e940.short?rss=1</link>
<description><![CDATA[In the years after the launch of the millennium development goals, the health economist Jeffrey Sachs emphasised investment in malaria control as the “lowest hanging fruit” in the battle to reduce child mortality.1 Such investment is paying off: cases of malaria and deaths from the disease, which mostly occur in young children, have fallen by more than 50% in nine African countries since 2000 through scaling up of malaria control tools.2 Yet despite this progress in controlling malaria and in scaling up other interventions such as vaccines, most countries are still not on track to achieve millennium development goal 4—that of reducing child mortality by two thirds from 1990 to 2015. With only four years until the deadline, we must now pursue other “low hanging fruit” that can rapidly reduce child mortality in developing countries.Investment in the treatment of diarrhoea with oral rehydration salts (ORS) plus zinc is one of...]]></description>
<dc:creator><![CDATA[Sabot, O., Schroder, K., Yamey, G., Montagu, D.]]></dc:creator>
<dc:date>2012-02-10T03:42:35-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e940</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e940</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Neurogastroenterology, Infectious diseases, Health policy, Epidemiologic studies, Child health, Pneumonia (respiratory medicine), Health economics, Health service research]]></dc:subject>
<dc:title><![CDATA[Scaling up oral rehydration salts and zinc for the treatment of diarrhoea]]></dc:title>
<prism:publicationDate>2012-02-10</prism:publicationDate>
<prism:section>Editorials</prism:section>
<prism:subsection1>Editorial</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb10_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e1020.short?rss=1">
<title><![CDATA[Critics attack DSM-5 for overmedicalising normal human behaviour]]></title>
<link>http://www.bmj.com/content/344/bmj.e1020.short?rss=1</link>
<description><![CDATA[Although not due to be published until May 2013, the fifth edition of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM-5) is already provoking dissent among psychiatrists and psychologists in Britain. Critics claim it will make an already problematic diagnostic system worse and result in more people being labelled mentally ill.Producing a new edition of the DSM is a major undertaking. This one, prompted by the accumulation of new information on neurology, genetics, and behavioural sciences, has been compiled by the 162 members of 13 separate work groups, helped by a further 300 advisors and informed by many open meetings.All this effort has failed, however, to create unanimity. “The new categories are based on lists of symptoms that don’t necessarily map well on to the underlying biological and psychological processes involved in emotion, behaviour, and cognition,” said Nick Craddock, professor of psychiatry at Cardiff University.Speaking at...]]></description>
<dc:creator><![CDATA[Watts, G.]]></dc:creator>
<dc:date>2012-02-10T03:42:35-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e1020</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e1020</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Health policy, Clinical diagnostic tests, Health economics, Health service research]]></dc:subject>
<dc:title><![CDATA[Critics attack DSM-5 for overmedicalising normal human behaviour]]></dc:title>
<prism:publicationDate>2012-02-10</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb10_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e1025.short?rss=1">
<title><![CDATA[Judges rule that hospitals have a duty to protect voluntary psychiatric patients]]></title>
<link>http://www.bmj.com/content/344/bmj.e1025.short?rss=1</link>
<description><![CDATA[Public institutions, including NHS hospitals, have a positive duty to safeguard the right to life of voluntary psychiatric patients as well as patients who are formally detained, the UK Supreme Court has ruled in a landmark judgment.Five judges ruled that Pennine Care NHS Trust breached Melanie Rabone’s right to life under article 2 of the European Convention on Human Rights when she was allowed to leave Stepping Hill Hospital in Stockport in April 2005 for two days’ home leave with her parents. She had been admitted to hospital as a voluntary patient after a second suicide attempt, and a day after going home she went for a walk and hanged herself from a tree.The Supreme Court’s judgment overturned rulings from the High Court and Court of Appeal, which held that the article 2 duty applied only to detained patients. The appeal court noted that NHS bodies would be laid open...]]></description>
<dc:creator><![CDATA[Dyer, C.]]></dc:creator>
<dc:date>2012-02-10T03:42:35-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e1025</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e1025</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Suicide (psychiatry), Ethics of reproduction, Human rights, Suicide (public health)]]></dc:subject>
<dc:title><![CDATA[Judges rule that hospitals have a duty to protect voluntary psychiatric patients]]></dc:title>
<prism:publicationDate>2012-02-10</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb10_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e346.short?rss=1">
<title><![CDATA[Delirium in intensive care patients]]></title>
<link>http://www.bmj.com/content/344/bmj.e346.short?rss=1</link>
<description><![CDATA[The scientific evidence is irrefutable—delirium in the intensive care unit is an independent predictor of death and acquired dementia.1 2 The linked study by Van den Boogaard and colleagues (doi:10.1136/bmj.e420) is the largest study on delirium in intensive care to date, and it provides a risk model to determine the likelihood of patients in intensive care developing delirium.3 The model (PRE-DELIRIC), which determines 10 risk factors, was developed and validated at the Radboud University Nijmegem Medical Centre in the Netherlands. It was then externally validated at four other Dutch hospitals. The risk model showed a high predictive value, and it was significantly better than the predictions of doctors and nurses.Reassuringly there are no surprises; risk factors that confer the highest risk are coma with any cause, sedatives, and infection. Notably there were too few patients with alcohol dependency or dementia for these subgroups to be included in the model. However,...]]></description>
<dc:creator><![CDATA[Page, V.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e346</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e346</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Infectious diseases, Urology, Coma and raised intracranial pressure, Memory disorders (neurology), Delirium, Memory disorders (psychiatry), Adult intensive care, Drugs: musculoskeletal and joint diseases, Urological surgery, Screening (epidemiology), Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Delirium in intensive care patients]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Editorials</prism:section>
<prism:subsection1>Editorial</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e420.short?rss=1">
<title><![CDATA[Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study]]></title>
<link>http://www.bmj.com/content/344/bmj.e420.short?rss=1</link>
<description><![CDATA[Objectives To develop and validate a delirium prediction model for adult intensive care patients and determine its additional value compared with prediction by caregivers.Design Observational multicentre study.Setting Five intensive care units in the Netherlands (two university hospitals and three university affiliated teaching hospitals).Participants 3056 intensive care patients aged 18 years or over.Main outcome measure Development of delirium (defined as at least one positive delirium screening) during patients’ stay in intensive care.Results The model was developed using 1613 consecutive intensive care patients in one hospital and temporally validated using 549 patients from the same hospital. For external validation, data were collected from 894 patients in four other hospitals. The prediction (PRE-DELIRIC) model contains 10 risk factors—age, APACHE-II score, admission group, coma, infection, metabolic acidosis, use of sedatives and morphine, urea concentration, and urgent admission. The model had an area under the receiver operating characteristics curve of 0.87 (95% confidence interval 0.85 to 0.89) and 0.86 after bootstrapping. Temporal validation and external validation resulted in areas under the curve of 0.89 (0.86 to 0.92) and 0.84 (0.82 to 0.87). The pooled area under the receiver operating characteristics curve (n=3056) was 0.85 (0.84 to 0.87). The area under the curve for nurses’ and physicians’ predictions (n=124) was significantly lower at 0.59 (0.49 to 0.70) for both.Conclusion The PRE-DELIRIC model for intensive care patients consists of 10 risk factors that are readily available within 24 hours after intensive care admission and has a high predictive value. Clinical prediction by nurses and physicians performed significantly worse. The model allows for early prediction of delirium and initiation of preventive measures.Trial registration Clinical trials NCT00604773 (development study) and NCT00961389 (validation study).]]></description>
<dc:creator><![CDATA[Boogaard, M. v. d., Pickkers, P., Slooter, A. J. C., Kuiper, M. A., Spronk, P. E., Voort, P. H. J. v. d., Hoeven, J. G. v. d., Donders, R., Achterberg, T. v., Schoonhoven, L.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e420</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e420</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Coma and raised intracranial pressure, Delirium, Memory disorders (psychiatry), Adult intensive care, Drugs: musculoskeletal and joint diseases, Screening (epidemiology), Metabolic disorders, Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e568.short?rss=1">
<title><![CDATA[John Michael Talbot]]></title>
<link>http://www.bmj.com/content/344/bmj.e568.short?rss=1</link>
<description><![CDATA[John Michael Talbot was born in Thames Ditton and educated at Kingston Grammar School. He came to living faith in his early teens through a boys’ bible class run by the Crusaders Union. He gained an undergraduate degree in medicine at London’s King’s College in the Strand, evacuated to Birmingham during the second world war, and completed his medical training at King’s College Hospital in south London.John Talbot served two years as an doctor in the Royal Air Force in Singapore before returning to London at the end of the war to gain an MD in bacteriology at the London School of Hygiene and Tropical Medicine. After graduating, he returned to Kings College Hospital as a lecturer and subsequently took up a position as a consultant bacteriologist at Kingston General Hospital.In 1954, he married Rosalyn Carrick and the couple moved to Croydon, where they raised three children and became active...]]></description>
<dc:creator><![CDATA[Blake, H.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e568</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e568</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[John Michael Talbot]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Obituaries</prism:section>
<prism:subsection1>Obituary</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e667.short?rss=1">
<title><![CDATA[Varicose veins]]></title>
<link>http://www.bmj.com/content/344/bmj.e667.short?rss=1</link>
<description><![CDATA[A 55 year old woman presents with a history of tortuous veins on both legs and a related ache towards the end of the day. She finds these veins unsightly and would like to know whether she can have them treated.What you should coverVaricose veins are very common: 40% of men and 32% of women aged 18-64 years have this condition.1Common presenting complaints are “heavy legs”, swelling, restless legs, cramps, itching, and tingling,2 but these symptoms are often unrelated to the presence of varicose veins.2Document risk factors such as increasing age, family history, obesity, and occupational history associated with prolonged standing.3 Varicose veins may first become apparent during pregnancy and the risk increases with parity.1 3Ask about red flag symptoms such as weight loss and rectal bleeding where varicose veins may be due to a pelvic or abdominal mass.Ask about previous treatment of varicose veins and outcome. Document a history...]]></description>
<dc:creator><![CDATA[Nogaro, M.-C., Pournaras, D. J., Prasannan, C., Chaudhuri, A.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e667</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e667</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Neurogastroenterology, 10-Minute Consultation, Pain (neurology), Sleep disorders (neurology), Obesity (nutrition), Pregnancy, Reproductive medicine, Venous thromboembolism, Sleep disorders, Radiology, Sleep disorders (respiratory medicine), Vascularitis, Dermatology, Clinical diagnostic tests, Vascular surgery, Health education, Obesity (public health), Health promotion]]></dc:subject>
<dc:title><![CDATA[Varicose veins]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Practice</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e902.short?rss=1">
<title><![CDATA[J Stephen D Allen]]></title>
<link>http://www.bmj.com/content/344/bmj.e902.short?rss=1</link>
<description><![CDATA[Shortly after qualifying J Stephen D Allen (“Steve”) decided to specialise in anaesthesia, and his intellect and energy were quickly recognised. His subspecialty interests lay in critical care medicine and cardiothoracic anaesthesia. He was awarded an MD for his research into the inflammatory and renal response to cardiopulmonary bypass in 2004, having been appointed to a consultant post by the Royal Victoria Hospital in 2003. Steve continued as he had started, quickly and seamlessly taking up the consultant role. His quiet demeanour concealed a determination, which could be steely, and an impatience to make a difference for the benefit of his patients and for the cardiac surgical unit. In the 15 months between the diagnosis of his terminal illness and his death, Steve’s unwavering Christian faith was evident to everyone; it was the reason for his mental strength and his desire to communicate the source of his peace to all...]]></description>
<dc:creator><![CDATA[Elliott, P., McBride, W., Bill, M.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e902</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e902</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[J Stephen D Allen]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Obituaries</prism:section>
<prism:subsection1>Obituary</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e904.short?rss=1">
<title><![CDATA[Elizabeth Mary Helen Veitch]]></title>
<link>http://www.bmj.com/content/344/bmj.e904.short?rss=1</link>
<description><![CDATA[Elizabeth Mary Helen Veitch (“Mary”) had recently established herself as a partner in Springfield Medical Practice in Arbroath, but during that short time immersed herself in the practice and community.Mary was born and brought up in Leicestershire, and her talent for music was apparent at a young age. She was enormously gifted as a violinist, and, although she trained as a classical player, her eclectic musical interests led her to be active in the folk scene in later life. She could easily have pursued a professional career in music, but her vocation led her to medicine and she qualified at the Royal Free in London in 1979. During her undergraduate years she continued to play the violin, led the university orchestra, and was a member of the European Doctors’ Orchestra, where she played under the baton of world famous musicians, such as Andre Previn, and the composer Sir Michael Tippett.After...]]></description>
<dc:creator><![CDATA[Watson, A., Ramsay, A.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e904</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e904</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Elizabeth Mary Helen Veitch]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Obituaries</prism:section>
<prism:subsection1>Obituary</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e907.short?rss=1">
<title><![CDATA[Russell Cherry]]></title>
<link>http://www.bmj.com/content/344/bmj.e907.short?rss=1</link>
<description><![CDATA[After house jobs and vocational training, Russell Cherry worked in general practice in Hall Green, Birmingham, before joining Jiggins Lane Medical Centre, the practice that became his passion. His enthusiasm ensured the practice was at the forefront in technology and quality. He was prescribing adviser in South Birmingham and was active in commissioning groups where he was sought after for his wise counsel.A GP trainer for many years, he inspired many future GPs. Before his illness became too disabling he was able to enjoy his retirement party where almost all his registrars came to pay tribute to him. He was an outstanding undergraduate GP tutor at Birmingham University, then an excellent clinical subdean, working with fifth year tutors.A superb general practitioner, he was able to communicate easily with people from all backgrounds. After starting treatment for his tumour he warmly encouraged patients to greet and talk with him in spite...]]></description>
<dc:creator><![CDATA[Chudley, S., Parle, J.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e907</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e907</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Russell Cherry]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Obituaries</prism:section>
<prism:subsection1>Obituary</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e909.short?rss=1">
<title><![CDATA[Jonathan Adekunle Magbadelo]]></title>
<link>http://www.bmj.com/content/344/bmj.e909.short?rss=1</link>
<description><![CDATA[Jonathan Adekunle Magbadelo worked as a doctor in the Grantham and Newark area in accident and emergency medicine and surgery before his enforced retirement because of ill health. He was raised by his grandmother and after a varied career, qualified in medicine after a biochemistry degree. He went back to Nigeria as an army doctor in the rank of major. His refusal to cooperate with the corruption then rife led to his lack of success in preferment. So he moved back to the UK and worked around the country until settling in Grantham. In his final years, he enjoyed brief happiness with another doctor whom he married in 1988; Camilla sadly died in 1995. Jonathan had glaucoma and was registered blind, although he still travelled back to Nigeria from time to time.His passion for Manchester United football club remained to the end. His last few years were tinged with sadness...]]></description>
<dc:creator><![CDATA[Vogt, S.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e909</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e909</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Jonathan Adekunle Magbadelo]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Obituaries</prism:section>
<prism:subsection1>Obituary</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e911.short?rss=1">
<title><![CDATA[Leslie Naftalin]]></title>
<link>http://www.bmj.com/content/344/bmj.e911.short?rss=1</link>
<description><![CDATA[After qualifying as a dentist in 1937, Leslie Naftalin followed four of his brothers into medicine. Before the war he was briefly in practice in Birmingham, and after service in the Royal Army Medical Corps, he returned to Glasgow to set up practice in the deprived areas of Townhead, and later in Provanmill and Balornock. He also worked part time for many years for the Ministry of Pensions. His early recollections of general practice were of diphtheria, tuberculosis, polio, and overwhelming infection—an exposure largely lost to succeeding generations. He was a huge advocate for the NHS, which brought equality of access to health for his patients. He retired aged 75 after 41 years of practice in Glasgow, but he continued his involvement in community and charitable work till his death. He leaves a wife, Beulah; four children, two of whom are doctors; 12 grandchildren; and 26 great-grandchildren.]]></description>
<dc:creator><![CDATA[Naftalin, N. J., Naftalin, A. A.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e911</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e911</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Leslie Naftalin]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Obituaries</prism:section>
<prism:subsection1>Obituary</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e912.short?rss=1">
<title><![CDATA[Pieter Van Boxel]]></title>
<link>http://www.bmj.com/content/344/bmj.e912.short?rss=1</link>
<description><![CDATA[After a year in Durban, Pieter Van Boxel moved to Britain, where he worked as a casualty officer in Bath, and a senior house officer in Guy’s Hospital before obtaining a Geoffrey Knight research fellowship at the Maudsley. He returned to Guy’s for his senior registrar years, where, famed for his dashing good looks and love of travel and good food, he met his future wife, Mo. In 1980 he took up his consultant post in west Berkshire, where he worked for the following 24 years. Pieter had an unmistakable clinical style; relishing the ridiculous and poised between irreverence and respect, he engaged children and parents into a therapeutic complicity that often surprised them back to health. When colleagues’ rooms were filled with child friendly paraphernalia, his remained an office in which he offered only himself. Pieter was one of the few therapists who could successfully and respectfully use paradox...]]></description>
<dc:creator><![CDATA[West, A.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e912</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e912</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Pieter Van Boxel]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Obituaries</prism:section>
<prism:subsection1>Obituary</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e996.short?rss=1">
<title><![CDATA[Appetite suppressant was probably responsible for 1300 deaths, study shows]]></title>
<link>http://www.bmj.com/content/344/bmj.e996.short?rss=1</link>
<description><![CDATA[A research study into the drug benfluorex (marketed as Mediator), which was withdrawn from the French market in 2009 because of side effects, shows that its use in France during 1976-2009 was probably responsible for around 1300 deaths and 3100 hospital admissions.The study, published in Pharmacoepidemiology and Drug Safety, was carried out by Agnès Fournier and Mahmoud Zureik, two epidemiologists from the Institut National de la Santé et de la Recherche Medical (Inserm) (2012, doi:10.1002/pds.3213).They warn that these figures may be underestimates. Patients who took the appetite-suppressant drug experienced valvular insufficiency. “We have worked with available data from hospitals activity monitoring and from Social Security reimbursements,” Dr Zureik explains. “The population we have studied consisted of 303 336 patients who had taken 78 million boxes of Mediator.” About 5 million people took the drug in the 33 years it was on the market.The results are published at a difficult time for...]]></description>
<dc:creator><![CDATA[Benkimoun, P.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e996</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e996</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Drugs: cardiovascular system, Echocardiography, Medicines regulation, Radiology, Clinical diagnostic tests, Radiology (diagnostics), Lipid disorders, Metabolic disorders]]></dc:subject>
<dc:title><![CDATA[Appetite suppressant was probably responsible for 1300 deaths, study shows]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e1000.short?rss=1">
<title><![CDATA[Doctors in Syria are being forced to treat patients in secret, charity says]]></title>
<link>http://www.bmj.com/content/344/bmj.e1000.short?rss=1</link>
<description><![CDATA[The medical charity Médecins Sans Frontières (MSF) has warned that the Syrian regime is using doctors and healthcare facilities as “tools of repression” and doctors are being forced to treat patients clandestinely.The charity held a press conference in Paris on 8 February where it showed video testimonies of patients who had escaped for treatment to neighbouring Jordan and Lebanon. It says it cannot verify any of the patients’ statements but “given the recurring nature, the consistency and the severity of the acts described” MSF decided to make the testimonies public.The charity does not have any official presence in Syria but it has made contact with doctors and other healthcare staff in the country to whom it has sent medical supplies.The conflict in Syria has intensified in recent days and there have been reports of hospitals and clinics being targeted by the military.The charity says hospitals are becoming militarised, with armed...]]></description>
<dc:creator><![CDATA[Gulland, A.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e1000</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e1000</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Haematology (incl blood transfusion)]]></dc:subject>
<dc:title><![CDATA[Doctors in Syria are being forced to treat patients in secret, charity says]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e1009.short?rss=1">
<title><![CDATA[Peers vote to put mental health on equal footing with physical health in the NHS]]></title>
<link>http://www.bmj.com/content/344/bmj.e1009.short?rss=1</link>
<description><![CDATA[Peers voted against the government on the Health and Social Care Bill at their first opportunity on 8 February when they backed an amendment to give mental and physical health equal weight in the NHS.The vote was won by a majority of four, by 244 votes to 240, with three Liberal Democrats voting against the government. The amendment creates a duty for the health secretary to promote a health service that deals with “mental and physical illness” rather than simple “illness” as stated in the original draft.The vote is an indication that peers are determined that the bill will not have an easy ride over the next few weeks. Peers will debate further amendments on 13 February.A spokesman from the department of health, however, downplayed the importance of the vote, saying the low priority given to mental health was being dealt with through the cross government mental health strategy.He added,...]]></description>
<dc:creator><![CDATA[Kmietowicz, Z.]]></dc:creator>
<dc:date>2012-02-09T07:44:26-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e1009</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e1009</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Peers vote to put mental health on equal footing with physical health in the NHS]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_3</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e536.short?rss=1">
<title><![CDATA[Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis]]></title>
<link>http://www.bmj.com/content/344/bmj.e536.short?rss=1</link>
<description><![CDATA[Objective To determine whether the acute consumption of cannabis (cannabinoids) by drivers increases the risk of a motor vehicle collision.Design Systematic review of observational studies, with meta-analysis. Data sources We did electronic searches in 19 databases, unrestricted by year or language of publication. We also did manual searches of reference lists, conducted a search for unpublished studies, and reviewed the personal libraries of the research team.Review methods We included observational epidemiology studies of motor vehicle collisions with an appropriate control group, and selected studies that measured recent cannabis use in drivers by toxicological analysis of whole blood or self report. We excluded experimental or simulator studies. Two independent reviewers assessed risk of bias in each selected study, with consensus, using the Newcastle-Ottawa scale. Risk estimates were combined using random effects models.Results We selected nine studies in the review and meta-analysis. Driving under the influence of cannabis was associated with a significantly increased risk of motor vehicle collisions compared with unimpaired driving (odds ratio 1.92 (95% confidence interval 1.35 to 2.73); P=0.0003); we noted heterogeneity among the individual study effects (I2=81). Collision risk estimates were higher in case-control studies (2.79 (1.23 to 6.33); P=0.01) and studies of fatal collisions (2.10 (1.31 to 3.36); P=0.002) than in culpability studies (1.65 (1.11 to 2.46); P=0.07) and studies of non-fatal collisions (1.74 (0.88 to 3.46); P=0.11). Conclusions Acute cannabis consumption is associated with an increased risk of a motor vehicle crash, especially for fatal collisions. This information could be used as the basis for campaigns against drug impaired driving, developing regional or national policies to control acute drug use while driving, and raising public awareness.]]></description>
<dc:creator><![CDATA[Asbridge, M., Hayden, J. A., Cartwright, J. L.]]></dc:creator>
<dc:date>2012-02-09T15:33:57-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e536</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e536</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, CME]]></dc:subject>
<dc:title><![CDATA[Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Research</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_2</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e595.short?rss=1">
<title><![CDATA[Driving while under the influence of cannabis]]></title>
<link>http://www.bmj.com/content/344/bmj.e595.short?rss=1</link>
<description><![CDATA[The findings of the linked paper by Asbridge and colleagues (doi:10.1136/bmj.e536) add weight to the argument that cannabis users should be deterred from driving while intoxicated because of the risk of injury or death to themselves and others.1 This systematic review of nine case-control studies and culpability studies found that recent cannabis use almost doubled the odds of having a motor vehicle crash (odds ratio 1.92, 95% confidence interval 1.35 to 2.73). The increased risk was marginally larger in better designed studies (2.21 v 1.78), in case-control rather than culpability studies (2.79 v 1.65), and in studies that examined deaths rather than injuries (2.10 v 1.74). The authors note that, although residual confounding is possible, their results are consistent with experimental evidence that cannabis use leads to dose related impairments in simulated driving, psychomotor skills, and on-road driving.2 3Public health education about the dangers of driving while under the influence...]]></description>
<dc:creator><![CDATA[Hall, W.]]></dc:creator>
<dc:date>2012-02-09T15:33:57-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e595</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e595</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Drug misuse (including addiction), Medicines regulation, Drug misuse]]></dc:subject>
<dc:title><![CDATA[Driving while under the influence of cannabis]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Editorials</prism:section>
<prism:subsection1>Editorial</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_2</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e697.short?rss=1">
<title><![CDATA[Our medical heritage has lessons for the future]]></title>
<link>http://www.bmj.com/content/344/bmj.e697.short?rss=1</link>
<description><![CDATA[The Oxford Handbook of the History of Medicine is a coming of age compendium. The call for a new approach to medicine’s past was made in the early 1970s. It aimed to release medical history from the grip of its “great men and great movements.” The new social history of medicine, rather than creating an ever more fine grained chronology of progress, sought instead to uncover the social determinants of health in their historical context. So successful has this been that Mark Jackson’s well edited volume has dispensed with the word “social” in its title and cut to the chase. What emerges clearly from this book is the breadth of today’s history of medicine and its integration with the methods and insights of the social sciences.On top of everything else they have to do, today’s doctors are often exhorted to develop their human side. Learning about the history of medicine...]]></description>
<dc:creator><![CDATA[Bynum, H.]]></dc:creator>
<dc:date>2012-02-09T03:45:02-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e697</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e697</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Our medical heritage has lessons for the future]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Views &#x26; Reviews</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e844.short?rss=1">
<title><![CDATA["n of 1" trials]]></title>
<link>http://www.bmj.com/content/344/bmj.e844.short?rss=1</link>
<description><![CDATA[Researchers investigated whether paracetamol was as effective as non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of pain and disability related to osteoarthritis of the hip or knee. A series of double blind, randomised “n of 1” controlled trials was performed. Each drug was taken for two weeks, administered for a maximum of five cycles. Thirteen patients in primary care who had regularly been using NSAIDS were selected. Patients received the same type of NSAID and in the same dosage, if possible, as they were taking before the start of the study. Outcome measures included severity of complaints of pain, stiffness, and limitations in daily functioning, together with satisfaction with drugs and side effects.1Seven patients completed the study, and it was recommended that six of these change to paracetamol. All the other patients continued with NSAIDs. Three months after the study finished, of the six patients for whom a change to...]]></description>
<dc:creator><![CDATA[Sedgwick, P.]]></dc:creator>
<dc:date>2012-02-09T03:45:02-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e844</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e844</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Clinical trials (epidemiology), General practice / family medicine, Statistics, Pain (neurology), Biological agents, Degenerative joint disease, Drugs: musculoskeletal and joint diseases, Musculoskeletal syndromes, Osteoarthritis]]></dc:subject>
<dc:title><![CDATA["n of 1" trials]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Endgames</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e922.short?rss=1">
<title><![CDATA[Donald Jeffries]]></title>
<link>http://www.bmj.com/content/344/bmj.e922.short?rss=1</link>
<description><![CDATA[bmj;344/feb09_1/e922/FIG1F1fig1The clinical virologist Professor Donald James Jeffries was at the forefront of the UK response to HIV and transmissible spongiform encephalopathies (TSEs). His prolific research programme in HIV/AIDS included studies into routes of infection, disease course, drug development, and trials of clinical treatments. Working with Roche on the development of saquinavir (Invirase), the first of the protease inhibitor class of antiretroviral drugs, was a critical step in the history of HIV therapy and underpinned remarkable advances in prognosis for people with HIV.Decontamination of surgical instrumentsDon’s legacy for HIV and TSEs includes a wealth of sensible guidance in some of the most challenging areas of medical and scientific policy and practice of the past 30 years. Examples include giving guidance on safe practices for healthcare workers with HIV; changing the life insurance industry’s code of practice to assess risk behaviour rather than sexual orientation when calculating premiums; advising on decontamination of...]]></description>
<dc:creator><![CDATA[Anderson, J., Ridgway, G.]]></dc:creator>
<dc:date>2012-02-09T03:45:02-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e922</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e922</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Donald Jeffries]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Obituaries</prism:section>
<prism:subsection1>Obituary</prism:subsection1>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e923.short?rss=1">
<title><![CDATA[In brief]]></title>
<link>http://www.bmj.com/content/344/bmj.e923.short?rss=1</link>
<description><![CDATA[Trusts are given access to PFI bailout fund: Seven hospital trusts in England with debts that are partly caused by private finance initiative repayments are to have access to a £1.5bn (€1.8bn; $2.4bn) government bailout fund over the 25 year course of the contracts. Without the fund, services at the trusts—Barking, Havering and Redbridge; St Helens  South London; Peterborough and Stamford; North Cumbria; Dartford and Gravesham; and Maidstone and Tunbridge Wells—would be at risk, said the Department of Health.Pfizer recalls a million packets of the pill in US: The drug company Pfizer has voluntarily recalled a million packages of oral contraceptives that were distributed in the United States. The blister packs may contain pills with the wrong amount of active ingredient or with pills in the wrong position in the packaging to correlate with the ovulation cycle. Lawyers are already soliciting for cases of unwanted pregnancy and “damages.”Obesity...]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2012-02-09T03:45:02-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e923</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e923</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Infectious diseases, Obesity (nutrition), Contraception, Drugs: obstetrics and gynaecology, Pregnancy, Reproductive medicine, Lung cancer (oncology), Paediatric oncology, Child health, Lung cancer (respiratory medicine), Dermatology, Health education, Obesity (public health), Health promotion]]></dc:subject>
<dc:title><![CDATA[In brief]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e971.short?rss=1">
<title><![CDATA[A commitment to protect health and save lives]]></title>
<link>http://www.bmj.com/content/344/bmj.e971.short?rss=1</link>
<description><![CDATA[At what age are surgeons safest? In France, according to Antoine Duclos and colleagues, it’s between 35 and 50 years old (doi:10.1136/bmj.d8041). The authors looked prospectively at thyroid operations performed in five high volume centres and found an increased risk of permanent complications when operations were done by less experienced surgeons and those in practice for more than 20 years. This finding has a certain face validity, but the authors recommend caution in interpreting their results. They looked at only one type of operation and used a cross sectional study design. Future research might follow a cohort of surgeons to see how performance changes during a surgeon’s career, they say. Supervision in the early years is an obvious response, but what should surgeons do when they reach 50?Surgical skill comes up elsewhere this week. Ruth Doherty and Zaki Almallah ask how urinary function after prostatectomy could be improved (doi:10.1136/bmj.d6298). As...]]></description>
<dc:creator><![CDATA[Godlee, F.]]></dc:creator>
<dc:date>2012-02-09T03:45:02-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e971</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e971</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Urology, Clinical trials (epidemiology), Epidemiologic studies, Incontinence, Urological surgery]]></dc:subject>
<dc:title><![CDATA[A commitment to protect health and save lives]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>Editor&#x27;s Choice</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e987.short?rss=1">
<title><![CDATA[Charity backtracks on cuts to Planned Parenthood funding]]></title>
<link>http://www.bmj.com/content/344/bmj.e987.short?rss=1</link>
<description><![CDATA[In the face of a public outcry, one of the largest cancer charities in the US, Susan G Komen for the Cure, has reversed its decision to stop giving grants for cancer screening of low income women through Planned Parenthood. The person at the centre of the controversy, vice president for policy Karen Handel, resigned on 7 February.The issue exploded in the media and online in late January when it became known that Komen would be ending grants totalling about $700 000 (£440 000; €530 000), to 19 Planned Parenthood affiliates (BMJ 2012:344:e870, doi:10.1136/bmj.e870).Komen first said it was because Planned Parenthood was under investigation for potential misuse of federal money for abortion services, but later said it was because it (Komen) had adopted a policy to fund only direct services, not referrals to other medical providers.The original action, shifting justification, and reversal only fuelled charges by supporters of Planned Parenthood that the decision...]]></description>
<dc:creator><![CDATA[Roehr, B.]]></dc:creator>
<dc:date>2012-02-09T03:45:02-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e987</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e987</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Contraception, Family planning, Screening (oncology), Screening (epidemiology), Ethics of abortion, Ethics of reproduction, Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Charity backtracks on cuts to Planned Parenthood funding]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e994.short?rss=1">
<title><![CDATA[Care home resident challenges PCT's right to hive off services to a social enterprise without a proper tendering process]]></title>
<link>http://www.bmj.com/content/344/bmj.e994.short?rss=1</link>
<description><![CDATA[A retired railwayman who lives in a care home challenged his local primary care trust’s decision to hive off community care services to a social enterprise company at the High Court in London this week.Lawyers for Michael Lloyd, 76, argue that Gloucestershire Primary Care Trust would be acting unlawfully in outsourcing the services to Gloucestershire Care Services Community Interest Company (GCS), a company it set up itself, without a transparent procurement exercise.David Lock QC, for Mr Lloyd, told the court that the trust’s proposal seemed to contradict all established principles of procurement law in suggesting it could enter into legally binding contracts with GCS worth £80m (€95m; $129m) a year for between three and five years without giving any other potential provider, whether private or NHS, the chance to be considered.The trust disputes Mr Lloyd’s standing to bring the case to court, accusing him of being a mouthpiece for Stroud...]]></description>
<dc:creator><![CDATA[Dyer, C.]]></dc:creator>
<dc:date>2012-02-09T03:45:03-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e994</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e994</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[General practice / family medicine, Physiotherapy, Sexual health, Sports and exercise medicine]]></dc:subject>
<dc:title><![CDATA[Care home resident challenges PCT's right to hive off services to a social enterprise without a proper tendering process]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e1005.short?rss=1">
<title><![CDATA[Faculty of Public Health calls for the health bill to be withdrawn]]></title>
<link>http://www.bmj.com/content/344/bmj.e1005.short?rss=1</link>
<description><![CDATA[The Faculty of Public Health has called for the “complete withdrawal” of the Health and Social Care Bill after members voted overwhelmingly for their leaders to change policy.The faculty surveyed its 3300 members after strong criticism of the board’s stance on the govenment’s health reforms surfaced at an emergency meeting in Birmingham on 25 January (BMJ 2012;344:e690, doi:10.1136/bmj.e690).Of those responding, 93% said that the Health and Social Care Bill, if passed, would damage the NHS and the health of people in England.Three-quarters of members called on the faculty to demand the complete withdrawal of the bill.The faculty said that almost 40% of members took part in the survey, with 1286 members responding online and 78 by post.Lindsey Davies, faculty president said, “We are now calling on the government to withdraw the bill in its entirety, because it would be in the best interests of everyone’s health.“Like our members, we make...]]></description>
<dc:creator><![CDATA[Limb, M.]]></dc:creator>
<dc:date>2012-02-09T03:45:03-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e1005</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e1005</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:subject><![CDATA[Patients, Health policy, Immunology (including allergy), Screening (epidemiology), Health service research, Housing and health, Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Faculty of Public Health calls for the health bill to be withdrawn]]></dc:title>
<prism:publicationDate>2012-02-09</prism:publicationDate>
<prism:section>News</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb09_1</prism:issueIdentifier>
</item>
<item rdf:about="http://www.bmj.com/content/344/bmj.e630.short?rss=1">
<title><![CDATA[The BMJ on the death of Charles Dickens]]></title>
<link>http://www.bmj.com/content/344/bmj.e630.short?rss=1</link>
<description><![CDATA[How true to Nature, even to their most trivial details, almost every character and every incident in the works of the great novelist whose dust has just been laid to rest, really were, is best known to those whose tastes or whose duties led them to frequent the paths of life from which Dickens delighted to draw. But none, except medical men, can judge of the rare fidelity with which he followed the great Mother through the devious paths of disease and death. In reading Oliver Twist and Dombey and Son, or The Chimes, or even No Thoroughfare, the physician often felt tempted to say, “What a gain it would have been to physic if one so keen to observe and so facile to describe had devoted his powers to the medical art.” It must not be forgotten that his description of hectic (in Oliver Twist) has found its way...]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2012-02-08T07:53:02-08:00</dc:date>
<dc:identifier>info:doi/10.1136/bmj.e630</dc:identifier>
<dc:identifier>hwp:master-id:bmj;bmj.e630</dc:identifier>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[The BMJ on the death of Charles Dickens]]></dc:title>
<prism:publicationDate>2012-02-08</prism:publicationDate>
<prism:section>Filler</prism:section>
<prism:volume>344</prism:volume>
<prism:issueIdentifier>feb08_3</prism:issueIdentifier>
</item>
</rdf:RDF>
